News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PCa Growth Slowed by 5-ARI, University Health Network Study


2/16/2011 6:37:36 AM

MedPageToday -- ORLANDO -- Men with early-stage prostate cancer had almost a 40% reduction in the risk of progression when treated with the drug dutasteride (Avodart) during active surveillance, according to data from a randomized trial.

Read at MedPageToday


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES